Bracco Imaging has expanded its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selectio...
Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug...
Singapore is expanding subsidised access to Roche’s Columvi, or glofitamab, for eligible patients with relapsed or...
Australian oncology biotechnology company Kazia Therapeutics has reported a 100% clinical benefit rate among the first s...
Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...
Artificial intelligence is increasingly being applied across early-stage drug discovery, but translating computational p...
Nanjing Leads Biolabs has announced that China’s Center for Drug Evaluation has accepted the New Drug Application ...
Brii Biosciences has advanced its internally developed mRNA therapeutic cancer vaccine BRII-5395 into clinical evaluatio...
As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
IASO Biotechnology has completed its acquisition of Singapore-based MediSix Therapeutics, expanding its international ce...
Happiest Health’s The Edge of Nutrition 2026 brought together nutrition experts, clinicians, researchers and welln...
CPHI South East Asia 2026 brought together more than 11,000 pharmaceutical professionals from over 70 countries at the Q...
A new way for hard-to-treat cancer cells to protect themselves from being killed by anti-cancer drugs has been found. Th...
Rege Nephro, a clinical-stage biotechnology startup focused on induced pluripotent stem (iPS) cell-based kidney regenera...
Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and paren...
Frederick Appelbaum, MD, executive vice president and professor in the clinical research division at Fred Hutch Cancer C...
Versiti, Inc., a nonprofit organization dedicated to improving blood health for patients everywhere, has joined the Bloo...
MEDIPOST has treated the first U.S. participant in its Phase III clinical trial evaluating an investigational mesenchyma...
ARIA Bioscience, Singapore’s longevity biotech commercialisation firm, is collaborating with the A*STAR Institute ...
Cell Therapies is pleased to support the launch of the CARTiEr E312 Phase I/Ib clinical trial in Australia, evaluating A...
India's Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-H...
Autolomous and Cellular Origins have announced end-to-end integration of their respective platforms, bringing full autom...
RoosterBio and Qkine have entered a distribution agreement to provide U.S. customers with a single-source platform for c...
Catalent and Nanoscope Therapeutics have expanded their partnership to support late-phase clinical development and comme...
